Dipeptidyl-Peptidase IV Inhibitors
Showing 26 - 50 of >10,000
Diabete Type 2 Trial in El Sadat (Sitagliptin 50 mg, Empagliflozin 12.5 MG, Sitagliptin 50 mg + Empagliflozin 12.5 MG)
Completed
- Diabete Type 2
- Sitagliptin 50 mg
- +3 more
-
El Sadat, EgyptUniversity of Sadat City
Apr 27, 2022
Type 2 Diabetes, Incretinomimetics, Pancreas Trial in Brussels (Incretinomimetics, DPP-4 inhibitors)
Recruiting
- Type 2 Diabetes
- +2 more
- Incretinomimetics
- DPP-4 inhibitors
-
Brussels, BelgiumGastroenterology Department Erasme Hospital
Mar 1, 2021
Type 2 Diabetes Trial in Hellerup (LY2403021, LY2403021 , Standardised liquid meal)
Completed
- Type 2 Diabetes
- LY2403021
- +6 more
-
Hellerup, DenmarkCenter for Diabetes Research, Gentofte Hospital, Copenhagen Univ
Apr 6, 2020
Abdominal Obesity, Type 2 Diabetes Trial in San Luis Potosi (Biguanide, DPP4 inhibitors, SGLT2 inhibitors)
Enrolling by invitation
- Abdominal Obesity
- Type 2 Diabetes
- Biguanide, DPP4 inhibitors, SGLT2 inhibitors
-
San Luis Potosi, MexicoMetabolic Research Unit
Sep 1, 2021
Empagliflozin in Type 2 Diabetes Population With and Without
Not yet recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin
- +3 more
-
Durham, North CarolinaDuke Clinical Research Institute
Aug 8, 2022
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development
Unknown status
- Bullous Pemphigoid
- data report
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Aug 16, 2018
Diabetes Complications, Periodontal Diseases Trial (Front view photography of the patient's oral cavity with the help of a
Not yet recruiting
- Diabetes Complications
- Periodontal Diseases
- Front view photography of the patient's oral cavity with the help of a smartphone in the diabetology department.
- (no location specified)
May 25, 2023
Healthy Volunteers Trial (gemigliptin and dapagliflozin 50/10 mg film-coated tablet (Fasting), gemigliptin and dapagliflozin
Not yet recruiting
- Healthy Volunteers
- gemigliptin and dapagliflozin 50/10 mg film-coated tablet (Fasting)
- gemigliptin and dapagliflozin 50/10 mg film-coated tablet (fed)
- (no location specified)
Oct 24, 2021
Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),
Completed
- Type 2 Diabetes
- Comparative Effectiveness of Glycemia-lowering Medications
- Sulfonylurea (glimepiride)
- +3 more
-
Birmingham, Alabama
- +35 more
Apr 13, 2022
Diabetes, Prostatic Hyperplasia Trial in Cairo (International prostate symptom score, Assessment of prostate volume, Pittsburgh
Completed
- Diabetes Mellitus
- Prostatic Hyperplasia
- International prostate symptom score
- +3 more
-
Cairo, Egypt
- +1 more
Nov 19, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors Trial in Frankfurt
Withdrawn
- SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
-
Frankfurt, GermanyDepartment of Cardiology
Aug 31, 2020
Type2 Diabetes Trial in Copenhagen (Placebo, GIP receptor antagonist, DPP-4 inhibitor)
Completed
- Type2 Diabetes
- Placebo
- +3 more
-
Copenhagen, Hellerup, DenmarkCenter for Clinical Metabolic Research
Mar 15, 2021
Type 2 Diabetes, Proteinuria Trial (Dipeptidyl Peptidase 4 Inhibitor, Sulfonylurea)
Completed
- Type 2 Diabetes Mellitus
- Proteinuria
- Dipeptidyl Peptidase 4 Inhibitor
- Sulfonylurea
- (no location specified)
Jun 12, 2019
Dipeptidyl Peptidase-4 Link With Oral Cancer and Premalignant
Completed
- Oral Premalignant Lesions as Leukoplakia and Lichen Planus
- Oral Cancer
- serum and unstimulated salivary samples
-
Fayoum, Egyptfaculty of dentistry, Fayoum university
Oct 16, 2023
Hyperglycemia, Covid19 Trial in Leòn (Linagliptin tablet, Insulin)
Completed
- Hyperglycemia
- Covid19
- Linagliptin tablet
- Insulin
-
Leòn, Guanajuato, MexicoHospital Regional de Alta Especialidad del Bajìo
Mar 19, 2021
DPP4 Inhibitor and Coronary Atherosclerosis in Patients
Completed
- Diabetes Mellitus
- DPP4-inhibitor
- No DPP4-inhibitor
-
Bucheon, Korea, Republic ofBucheon St. Mary's Hospital
Apr 26, 2021
T2DM (Type 2 Diabetes), Diet, Healthy, Renal Function Disorder Trial in Milano (Sulfa-zero: possible benefits of the treatment
Recruiting
- T2DM (Type 2 Diabetes Mellitus)
- +3 more
- Sulfa-zero: possible benefits of the treatment of new generation hypoglycaemic drugs compared to sulphonylureas
-
Milano, ItalyASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico
Sep 27, 2021
Based on Data From German Sick Funds That Looks at Costs of
Completed
- Diabetes Mellitus, Type 2
- Empagliflozin
- +3 more
-
Ingelheim am Rhein, GermanyBoehringer Ingelheim
Jan 18, 2022
Type 2 Diabetes Trial in Seongnam (Sitagliptin, Dapagliflozin, Lobeglitazone)
Completed
- Type 2 Diabetes
- Sitagliptin
- +4 more
-
Seongnam, Gyeonggi, Korea, Republic ofSoo Lim
Jan 2, 2022
NAFLD Trial (sitagliptin and metformin, Sitagliptin, Metformin)
Completed
- NAFLD
- sitagliptin and metformin
- +2 more
- (no location specified)
Jul 28, 2022
Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)
Completed
- Type II Diabetes in Subjects BMI 27 to 32
- Roux-en-Y Gastric Bypass (RYGB)
- +4 more
-
Singapore, SingaporeKhoo Teck Puat Hospital
Jun 22, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo (insulin 287), Metformin)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +5 more
-
Lancaster, California
- +48 more
Mar 5, 2021
PreDiabetes Trial in Leon (Black bean protein hydrolysates (BPH), Commercial non-caloric beverage)
Completed
- PreDiabetes
- Black bean protein hydrolysates (BPH)
- Commercial non-caloric beverage
-
Leon, Guanajuato, MexicoUniversidad de Guanajuato
May 19, 2023